
Devin Schweppe
@dschweppe1
Assistant Professor @uwgenome developing proteomic technologies | he/him/his | Views are my own.
ID: 1014155290076381190
https://www.schweppelab.org/ 03-07-2018 14:33:58
937 Tweet
1,1K Takipçi
516 Takip Edilen




I'm happy to report the publication of our latest #proteomics paper has been published in Nature Communications . Thanks to the reviewers and editors who helped us improve the manuscript! A small 🧵below nature.com/articles/s4146…



I’m excited to share the first preprint out of the Altemose Lab! This stems from a heroic effort by Dr. Matt Franklin Matt Franklin (who's on the job market!), who made surprising discoveries regarding some of the most mysterious regions of the genome. biorxiv.org/content/10.110…

Excited to share our chemoproteogenomics story now out in its final form in Nature Communications. Congrats to first author Heta Desai Heta Desai! nature.com/articles/s4146…

This is great! NIAID News have launched a collection of public domain illustrations (currently 550 individual icons) bioart.niaid.nih.gov



Beyond thrilled to present our O-MAP—now *published* Nature Methods (!!!) O-MAP is a powerful new method for biochemically "dissecting" the subcellular microenvironment around an RNA of interest, using off-the-shelf parts and standard manipulations. 🧵 nature.com/articles/s4159…

...and the O-MAP hits keep coming! Exciting new work spearheaded by @oligopain and Devin Schweppe is now applying O-MAP to *DNA LOCI* 👀. A super exciting project for which we're humbled to have played a part. Congrats to the entire team!! tinyurl.com/msr7e7wt

Blood donors offer a window into "healthy" aging. Now out Aging Cell, we report that arginine metabolism in >13k blood units, 587 sickle cell patients and 525 diversity outbred mice was linked to donor and RBC age, vesiculation and transfusion efficacy doi.org/10.1111/acel.1…



🔬 Exciting joint postdoc opportunity between Brooke E. Howitt Stanford Medicine and us BIDMC Harvard Medical School! Join us in advancing cancer research through computational & spatial genomics. Focus on gynecologic cancers & womens health at Boston/Stanford nature.com/naturecareers/…


AI Proteins is excited to partner with Bristol Myers Squibb to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes. businesswire.com/news/home/2024…

This JAMA Insights explores the capability of proteomics to analyze thousands of proteins in patient samples, which could improve clinicians’ understanding of and ability to treat a wide range of diseases. ja.ma/4jvNHbP Devin Schweppe